These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36216758)

  • 1. Current Practice Patterns in Locally Advanced Rectal Cancer at Academic Institutions: A National Survey Among Radiation Oncologists, Medical Oncologists, and Colorectal Surgeons.
    Wu TC; Sanford NN; Anand S; Chu FI; Wo JY; Raldow AC
    Clin Colorectal Cancer; 2022 Dec; 21(4):309-314. PubMed ID: 36216758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
    Mowery YM; Salama JK; Zafar SY; Moore HG; Willett CG; Czito BG; Hopkins MB; Palta M
    Cancer; 2017 Apr; 123(8):1434-1441. PubMed ID: 27984651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: a multicenter, randomized controlled trial (SOLAR trial).
    Kang MK; Park SY; Park JS; Kim HJ; Kim JG; Kang BW; Baek JH; Cho SH; Seo AN; Kim DW; Kim J; Baek SJ; Kim JH; Kim JY; Ha GW; Park EJ; Park IJ; Kim CH; Kang H; Choi GS
    BMC Cancer; 2023 Nov; 23(1):1059. PubMed ID: 37923987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A contemporary assessment of total neoadjuvant therapy (TNT) protocols for locally advanced rectal cancer: adoption and expert perspectives at German Cancer Society (DKG)-certified colorectal cancer centers.
    Langheinrich M; Paasch C; Mantke R; Weber K; Benz S; Kersting S
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12591-12596. PubMed ID: 37438538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study.
    Hoendervangers S; Sparreboom CL; Intven MPW; Lange JF; Verkooijen HM; Doornebosch PG; van Grevenstein WMU;
    Eur J Surg Oncol; 2020 Sep; 46(9):1605-1612. PubMed ID: 32192792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of total neoadjuvant therapy in locally advanced rectal cancer: a survey of specialists attending the All-Ireland Colorectal Cancer Conference 2022 including lead investigators of OPRA, PRODIGE-23 and RAPIDO.
    O'Brien T; Hospers G; Conroy T; Lenz HJ; Smith JJ; Andrews E; O'Neill B; Leonard G
    Ir J Med Sci; 2024 Jun; 193(3):1183-1190. PubMed ID: 38141097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial).
    Akiyoshi T; Shinozaki E; Taguchi S; Chino A; Hiratsuka M; Tominaga T; Nonaka T; Toda S; Matoba S; Matsui S; Okabayashi K; Mukai T; Hiyoshi Y; Yamaguchi T; Nagasaki T; Yamaguchi K; Ueno M; Kuroyanagi H; Fukunaga Y; Ishizuka N; Konishi T;
    BMJ Open; 2022 Mar; 12(3):e055140. PubMed ID: 35304396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise neoadjuvant chemoradiotherapy in the management of mid-low locally advanced rectal cancer.
    Zhang YX; Liu HY; Jiang B; Wang WY; Wang HB; Lu YJ
    Eur J Surg Oncol; 2020 Mar; 46(3):410-414. PubMed ID: 31627933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of short-course radiotherapy with total neoadjuvant therapy in the treatment of middle and low rectal cancer].
    Chen CJ; Yang CK; Jian JL; Guan S; Xie MM
    Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(4):271-277. PubMed ID: 36660788
    [No Abstract]   [Full Text] [Related]  

  • 12. Post-Operative Morbidity and Mortality Following Total Neoadjuvant Therapy Versus Conventional Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Sutera P; Solomina J; Wegner RE; Abel S; Monga D; Finley G; McCormick J; Kirichenko AV
    J Gastrointest Cancer; 2021 Sep; 52(3):976-982. PubMed ID: 32936391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 14. Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH).
    Wang Y; Shen L; Wan J; Zhang H; Wu R; Wang J; Wang Y; Xu Y; Cai S; Zhang Z; Xia F
    BMC Cancer; 2022 Mar; 22(1):274. PubMed ID: 35291966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer.
    Chin RI; Otegbeye EE; Kang KH; Chang SH; McHenry S; Roy A; Chapman WC; Henke LE; Badiyan SN; Pedersen K; Tan BR; Glasgow SC; Mutch MG; Samson PP; Kim H
    JAMA Netw Open; 2022 Feb; 5(2):e2146312. PubMed ID: 35103791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
    BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensified Total Neoadjuvant Therapy
    DE Felice F; Musio D; Iafrate F; Caponnetto S; Picone V; D'Ambrosio G; Magliocca FM; Tozzi F; DE Toma G; Tombolini V; Cortesi E
    Anticancer Res; 2022 Feb; 42(2):991-1000. PubMed ID: 35093899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total neoadjuvant therapy for rectal cancer: An emerging option.
    Ludmir EB; Palta M; Willett CG; Czito BG
    Cancer; 2017 May; 123(9):1497-1506. PubMed ID: 28295220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Findings in magnetic resonance imaging for restaging locally advanced rectal cancer.
    Marjasuo S; Koskenvuo L; Lepistö A
    Int J Colorectal Dis; 2024 Jan; 39(1):23. PubMed ID: 38289485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of neoadjuvant therapy for locally advanced rectal cancer in Wuhan Union Hospital Cancer Center.
    Zhai ML; Zhang FY; Yang JR; Zhang S; Zhao L; Lin ZY; Wang J; Yu DD; Zhang T
    Radiat Oncol; 2022 Jun; 17(1):109. PubMed ID: 35718789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.